Cited by 574Influenza Virus Research StudiesPneumonia and Respiratory InfectionsRespiratory viral infections research

The DOI matches its Crossref record; 65 of the 66 references it cites were found in a registry or an index; none of the 44 sources its claims cite is checked for support yet.

The frequency of influenza and bacterial coinfection: a systematic review and meta-analysis.

Open access
Klein, Eili Y., Monteforte, Bradley, Gupta, Alisha, Jiang, Wendi, May, Larissa, Hsieh, Yu‐Hsiang, Dugas, Andrea·2016·Influenza and Other Respiratory Viruses

Abstract

Aim: Coinfecting bacterial pathogens are a major cause of morbidity and mortality in influenza. However, there remains a paucity of literature on the magnitude of coinfection in influenza patients. Method: A systematic search of Me SH , Cochrane Library, Web of Science, SCOPUS , EMBASE , and PubMed was performed. Studies of humans in which all individuals had laboratory confirmed influenza, and all individuals were tested for an array of common bacterial species, met inclusion criteria. Results: Twenty‐seven studies including 3215 participants met all inclusion criteria. Common etiologies were defined from a subset of eight articles. There was high heterogeneity in the results ( I 2 = 95%), with reported coinfection rates ranging from 2% to 65%. Although only a subset of papers were responsible for observed heterogeneity, subanalyses and meta‐regression analysis found no study characteristic that was significantly associated with coinfection. The most common coinfecting species were Streptococcus pneumoniae and Staphylococcus aureus , which accounted for 35% (95% CI , 14%–56%) and 28% (95% CI , 16%–40%) of infections, respectively; a wide range of other pathogens caused the remaining infections. An assessment of bias suggested that lack of small‐study publications may have biased the results. Conclusions: The frequency of coinfection in the published studies included in this review suggests that although providers should consider possible bacterial coinfection in all patients hospitalized with influenza, they should not assume all patients are coinfected and be sure to properly treat underlying viral processes. Further, high heterogeneity suggests additional large‐scale studies are needed to better understand the etiology of influenza bacterial coinfection.

Overview

AI snapshot

Written from the paper’s full text.

TL;DR

This systematic review and meta-analysis found that bacterial coinfection in laboratory-confirmed influenza patients was highly variable across studies, with reported rates from 2% to 65%. Streptococcus pneumoniae and Staphylococcus aureus were the most common coinfecting pathogens, but heterogeneity was too high to support a single pooled coinfection estimate.

Key findings

  • Twenty-seven studies including 3215 participants met inclusion criteria; reported bacterial coinfection ranged from 2% to 65%, with high heterogeneity (I² = 95%).
  • Among eight studies with species-level data (334 patients), S. pneumoniae accounted for 35% (95% CI, 14%–56%) and S. aureus for 28% (95% CI, 16%–40%) of identified coinfecting bacteria.
  • After excluding seven studies that contributed more than 50% of heterogeneity, the remaining 20 studies representing 64% of patients had coinfection proportions between 11% and 35% (I² = 37%).
  • No study characteristic examined—age, setting, enrollment year, study design, study size, or bacterial collection/detection method—was significantly associated with coinfection frequency.

Methods

  • Systematic review and meta-analysis reported per PRISMA, searching MeSH, Cochrane Library, Web of Science, SCOPUS, EMBASE, and PubMed in August 2014; inclusion required human studies with all individuals having laboratory-confirmed influenza and all tested for common bacterial species.
  • Data from 27 observational studies (13 prospective, 14 retrospective) were extracted; most enrolled hospitalized patients, with 11 studies focused on ICU patients, 10 on non-ICU hospitalized patients, 3 on ED patients, and 2 on mixed inpatient/outpatient settings.
  • Coinfection frequency was analyzed using the DerSimonian-Laird method in R’s metafor package; heterogeneity was quantified with I², and meta-regression, leave-one-out analysis, and Cook’s distances were used to explore heterogeneity.

Limitations

  • The paper states that the sample of 27 studies and >3000 patients is small relative to annual influenza-related hospitalizations; studies included only hospitalized patients with moderate to severe influenza, so outpatients and asymptomatic patients are not represented.
  • The paper states that bacterial detection methods varied in sensitivity and sampling site, potentially underdiagnosing difficult-to-detect bacteria; antibiotic use before or at enrollment was not systematically assessed and may have led to underestimation.
  • The paper states that significant heterogeneity could not be explained by measured study characteristics; evident from the text, all included studies were observational and most were small cohort studies, with selection bias and data-collection reliability concerns noted in the quality assessment.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1111/irv.12398

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Verification

Claims the paper makes

0 of 44 cited sources checked · 0 supported · 0 flagged

Show all 53 claims

  • Probably not a substantial claim. 20
  • It may state two separate claims as one. 33
44 of 44
  • The authors state this as an assumption.

    Coinfection was assumed to be any acute bacterial infection identified in respiratory secretions, sputum, or sterile site (e.g., bacteremia).

    “Coinfection was assumed to be any acute bacterial infection identified in respiratory secretions, sputum, or sterile site (e.g., bacteremia).”
  • The paper relies on this without support.

    Differentiating viral from bacterial infection remains a challenge for clinicians.

    “Differentiating viral from bacterial infection remains a challenge for clinicians.”
2 of 2

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

  • Mixed-setting total includes an uncounted third study

    Minor

    The two cited mixed-setting studies have 833 and 160 patients, totaling 993 rather than 1100. Table 1 lists a third mixed-setting study, Carr et al. (107 patients), which brings the total to 1100.

    Reported 1100 · recomputed 993

1 of 1

Citations

Cites

Flagged first, then by citations

Show all 66 references

1 of the 66 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

  1. National Collaborating Centre for Methods and Tools. Quality Assessment Tool for Quantitative Studies. Vol (Updated 13 April, 2010, Hamilton, 2008
  2. Dave BM, 2014, Clinical data of h1n1 infected patients, 2012–2013, Indian J Crit Care Med, 18, S25
  3. Guervilly C, 2010, High levels of procalcitonin and (greater‐than or equal to) reactive protein during H1N1 illness, Intensive Care Med, 36, S138
  4. Yan XX, 2011, Influenza a (H1n1) virus complicated with bacteria infection, Respirology, 16, 60

Cited by

Sorted by citations

Items 401–500 of 571

Metadata

Authors
Klein, E. Y., Monteforte, B., Gupta, A., Jiang, W., May, L., Hsieh, Y., & Dugas, A.
Affiliations
  • Center for Disease Dynamics, Economics & Policy (US)
  • Eastern Virginia Medical School (US)
  • Allegheny General Hospital (US)
  • George Washington University (US)
  • Johns Hopkins University (US)
Corresponding author
Klein, Eili Y.
Venue
Influenza and Other Respiratory Viruses
Publisher
Wiley
Published
2016-06-24
Volume
10
Issue
5
Pages
394-403
ISSN
  • 1750-2640 (ISSN-L)
  • 1750-2659
OpenAlex
W2402456610
Cited by
574
References
66
Citations by year
2026: 29 · 2025: 46 · 2024: 51 · 2023: 96 · 2022: 104 · 2021: 112 · 2020: 58 · 2019: 20 · 2018: 24 · 2017: 15 · 2016: 5
FWCI
2.89
Type
journal article
Language
en
Open access
Locations
  • Influenza and Other Respiratory Viruses (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
Funders
U.S. Department of Health and Human Services (IDSEP130014‐01‐00)
Topics
  • Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
  • Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
  • Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
Keywords
influenza, bacterial co-infection, Streptococcus pneumoniae, Staphylococcus aureus, hospitalized influenza patients, pathogenic bacteria
MeSH terms
Adolescent, Adult, Child, Child, Preschool, Female, Hospitalization, Humans, Infant, Infant, Newborn, Influenza, Human, Male, Middle Aged, Pneumococcal Infections, Staphylococcal Infections, Streptococcus pneumoniae, Drug Resistance, Bacterial, Methicillin-Resistant Staphylococcus aureus, Young Adult, Coinfection

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

A language model drew the claims from the paper on 2026-10-09, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-09 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review